5,N,N-TMT

drugbox
IUPAC_name = (2-(5-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine

---

width = 140
CAS_number = 22120-39-4
ATC_prefix =
ATC_suffix =
PubChem = 1837
C=13 | H=18 | N=2
molecular_weight = 202.30 g/mol
smiles =
melting_point =
melting_high =
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category =
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =

5,"N","N"-trimethyltryptamine (5,"N","N"-TMT; 5-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was first made in 1958 by E. H. Young. [ Young EH, J. Chem. Soc. 3493 (1958) ] In animal experiments it was found to be in between DMT and 5-MeO-DMT in potency [ Glennon et al, J. Med. Chem. 22:428-432 (1979) ] [ Glennon RA, Young R, Rosecrans JA, Kallman MJ. Hallucinogenic agents as discriminative stimuli: A correlation with serotonin receptor affinities.Psychopharmacology (Berlin). 1980 May, 68(2): 155-158 ] which would suggest an active dosage for humans in the 20-60mg range. Human psychoactivity for this compound has been claimed in reports on websites such as Erowid but has not been independently confirmed.

References